Modern aspects of postinfectious salmonella carrying in children


DOI: https://dx.doi.org/10.18565/epidem.2019.9.1.62-70

Milutina L.N., Golubev A.O., Andronova T.M.

1 Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 2 Z.A. Bashlyaeva City Children’s Clinical Hospital, Moscow Healthcare Department, Moscow, Russia; 3 JSC Peptek, Moscow, Russia
The review presents domestic and foreign data on the main contemporary problems of postinfectious Salmonella carrying, especially in children: its epidemiological and social significance; frequency, duration, and influence of various factors (type and properties of the pathogen, age, and premorbid background of children, type of treatment in the acute phase of the disease); immunopathogenetic mechanisms; the effectiveness of different therapies; possible ways for prediction and prevention. It was concluded that it would be advisable to continue research on this topical issue, primarily in relation to the prognosis and prevention of long-term (more than 1.5 months) postinfectious salmonella carrying in children.
Keywords: immunopathogenesis, post-infectious bacteria carrying, salmonella, frequency, children, prediction, treatment, prevention
Read entire article

Literature

  1. Onishchenko G.G. [Maintaining the health of the nation – the fight against infectious and parasitic diseases]. Infektsionnye bolezni 2007; (5): 10–4. (In Russ.).
  2. Onishchenko G.G. [Incidence of аcute intestinal infections in the Russian Federation]. Immunologiya 2008; (1): 18–23. (In Russ.).
  3. [Information on infectious and parasitic diseases in January–December 2017 in the Russian Federation]. Detskiye infektsii 2018; 17(2): 5. (In Russ.).
  4. Rozhnova S.Sh., Frolochkina T.I., Golovanova M.A. [Epidemiological situation on salmonellosis in Russia at the turn of the century. Materials of the VIII Congress of the All-Russian Scientific and Practical Society of Epidemiologists, Microbiologist, and Parasitologists]. Мoscow, 2002; 1: 91–2. (In Russ.).
  5. Milutina L.N., Rozhnova S.Sh. [Evolution of clinical and epidemiological characteristics of salmonellosis in children. In: Proceedings of the scientific conference «Research in the field of applied sciences»]. Arad, Israel: Institute for Applied Research, 2013; 116–21. (In Russ.).
  6. Milutina L.N., Rubleva O.V., Golubev A.O., Ploskireva A.A., Gorelov A.V. [A practical guide to the diagnosis and treatment of salmonellosis in children]. Moscow, 2014. 93 p. (In Russ.).
  7. Bukharin O.V., Usvyattsev B.J. [Bacteriocarrier (medical and environmental aspects)]. Ekaterinburg: Uralskoye otdeleniye Rossiyskoy akademii nauk, 1996. 203 p. (In Russ.).
  8. Bukharin O.V. [Persistence of bacterial pathogens as a physiological phenomenon]. Vestnik Moskovskogo universiteta. Seriya 16. Biologiya. 2008; (1): 6–13. (In Russ.).
  9. Belyakov V.D., Golubev D.B., Klinskaya G.D. et al. [Self-parasite systems]. Moscow: Medicine 1987; 240 p. (In Russ.)
  10. Yakovlev A.A. [On possible mechanisms of development of the epidemic process].. Èpidemiologiâ i infekcionnye bolezni. Аktual’nye voprosy 2014; (6): 52–6. (In Russ.).
  11. Danilowicz D., Posnock E., Chase R., Spencer F.C. Salmonella Septicemia after open heart surgery in an asymptomatic carrier. Am. J. Cardiol. 1974; 34(7): 864–7.
  12. Berezin E.N., Carvalho E.S., Farhat C.K., Mimica I.M., Mimica L., Raphaelian T.A. Persistence of colonization time in patients infected by Salmonella. AMB Rev. Assoc. Med. Bras. 1990; 36(2): 100–6.
  13. Marri D., еd. [Infectious diseases in children]. 21 ed. Мoscow: Praktika, 2006. 928 p. (In Russ.).
  14. Svenungsson B., Goffe G. Persistent excretion of Salmonella in foreign-born adopted and native Swedish children. Scand. J. Infect. Dis. 1990; 22: 37–42.
  15. Fabre L., Delaune A., Espié E., Nygard K., Pardos M., Polomack L.:et al. Chromosomal integration of the extended-spectrum b-lactamase gene blaCTX-M-15 in Salmonella enterica serotype Concord isolates from internationally adopted children. Antimicrob. Agents Chemother. 2009; 53: 1808–16.
  16. Boisrame-Gastrin S., Tande D., Munck M.R., Gouriou S., Nordmann P., Naas T. Salmonella carriage in adopted children from Mali: 2001–08. J. Antimicrob. Chemother. 2011; 66: 2271–76.
  17. Nelson S.J., Granoff D. Salmonella gastroenteritis in the first three months of life. Clinical Pediatrics 1982; 21: 709–12.
  18. Kafetzis D.A., Maltezou H.C., Zafeiropoulou A., Attilakos A., Stavrinadis C., Foustoukou M. Epidemiology, clinical course and impact on hospitalization costs of acute diarrhea among hospitalized children in Athens, Greece. Scand. J. Infect. Dis. 2001; 33: 681–5.
  19. Buchwald D.S., Blaser M.J. A review of human salmonellosis, II: duration of excretion following infection with nontyphi Salmonella. Rev. Infect. Dis. 1984; 6: 345–56.
  20. Schutze G.E., Kirby R.S., Flick E.L. Epidemiology and Molecular Identification of Salmonella Infections in Children. Archives of Pediatrics and Adolescent Medicine 1998; 152: 659–64.
  21. Ivanova V.V., ed. [Infectious diseases in children]. Мoscow: Meditsinskoye informatsionnoye agentstvo, 2002. 928 p. (In Russ.).
  22. Lavrinovich D.N., Semenov V.M., Dmitrachenko T.I. [Clinical features of hospital salmonellosis]. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta 2007; 6(3): 1–10. (In Russ.).
  23. Milutina L.N., Golubev A.O., Guryeva O.V. et al. [On the issue of post-infectious bacteriocarrier in children with salmonellosis and ways of its correction]. Zhurnal infektologii 2010; 2(3): 126–7. (In Russ.).
  24. Kirillova T.A., Khabudayeva V.A., Kiklevich V.T. [Clinical and epidemiological features of salmonellosis caused by Salmonellae oranierburg. Proceedings of the IV Annual All-Russian Congress on Infectious Diseases]. Мoscow, 2012; 179. (In Russ.)
  25. Bekhtereva M.K., Tikhomirova O.V., Lachkova L.V., Kvetnaya A.S. [Features of the course of salmonellosis in children at the present stage and tactics of therapy. Materials of the All-Russian scientific-practical conference «Therapy of infectious diseases in children: modern ideas and unresolved issues»]. Saint-Petersburg, 2005; 24. (In Russ.).
  26. Asercoff B., Benett J.V. Effect of antibiotic therapy in acute salmonellosis on the faecalexcretion of salmonellae. New End. J. Med. 1969; 281: 636–400.
  27. Robert-Koch-Institut und Bundesinstitut für gesundhetlichen Verbraucherschutz und Veterinärmedizin (Hrg.). Salmonellose – Erkennunag, Bekämpfung, Verhütung. Merkblatt für Ärzte. Bundesgesungheitsbl. 1997; (1): 36–8.
  28. Vorotyntseva N.V., Mvazenkova L.N. [Acute intestinal infections in children]. Moscow: Meditsina 2001; 477. (In Russ.).
  29. Gonzalez-Escobedoa G., Gunn J.S.. Gallbladder Epithelium as a Niche for Chronic Salmonella Carriage. Infect. Immun. 2013; 81(8): 2920–30.
  30. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial Biofilms: A Common Cause of Persistent Infections. Science 1999; 284: 1318–22.
  31. Ponomareva A.L., Eskova A.I., Bakunina M.S. [Features of biofilm formation by bacteria of the genus Salmonella. Actual Questions of modern medicine. Materials of the II Far Eastern Medical Youth Forum]. Khabarovsk: Izdatelstvo Dalnevostochnogo gosudarstvennogo meditsinskogo universiteta 2018; 55–6. (In Russ.). http://www.fesmu.ru/elib/Book.aspx?id=206725
  32. Didenko L.V., Andreyevskaya S.G., Tiganova I.G., Smirnova T.A.. Romanova Yu.M. [The role of Salmonella in biliary lithogenesis]. Eksperimentalnaya i klinicheskaya gastroenterologiya 2009; (3): 44–7.
  33. Chaynikova I.N., Smolyagin A.I., Skachkov M.V., Kalinina T.N., Bucharin O.V. [Local immunity and intestinal microflora in salmonella bacteriocarrier and approaches to its rehabilitation]. Meditsinskaya immunologiya 2008; 10(1): 35–42. (In Russ.).
  34. Kvetnaya A.S., Bekhtereva M.K., Zheleznova L.I., Kalinogorskaya O.S. [The use of cycloferon in the treatment of salmonella and yersiniosis infections in children]. Antibiotiki i khimioterapiya 2012; 57(3–4): 9–16. (In Russ.).
  35. Virtala M., Kirveskari J., Granfors K. HLA-B27 Modulates the Survival of Salmonella Enteritidis in Transfected L Cells, Possibly by Impaired Nitric Oxide Production. Infect. Immun. 1997; 65(10): 4236–42.
  36. Rohekar S., Tsui F.W., Tsui H.W., Xi N., Riarh R., Bilotta R. et al. Symptomatic acute reactive arthritis after an outbreak of salmonella. J. Rheumatol. 2008; 35(8): 1599–602.
  37. Grigorovich M.S., Yurlova E.V., Okatova A.V. [Clinical and epidemiological characteristics and some features of enzymatic homeostasis in children with Salmonella infection]. Detskiye infektsii 2011; (3): 27–32. (In Russ.).
  38. Duerr C.U., Zenk S.F., Chassin C., Pott J., Gutle D. et al. O-Antigen Delays Lipopolysaccharide Recognition and Impairs Antibacterial Host Defense in Murine Intestinal Epithelial Cells. PLoS Pathog. 2009; 5(9): e1000567. DOI:10.1371/journal.ppat.1000567.
  39. Szeto J., Namolovan A., Osborne S.E., Coombes B.K., Brumell J.H. Salmonella-Containing Vacuoles Display Centrifugal Movement Associated with Cell-to-Cell Transfer in Epithelial Cells. Infect. Immun. 2009; 77(3): 996–1007.
  40. Prost L.R., Sanowar S., Miller S.I. Salmonella sensing of anti-microbial mechanisms to promote survival within macrophages. Immunol. Rev. 2007; 219: 55–65.
  41. Lapaque N., Walzer T., Méresse S., Vivier E., Trowsdale J. Interactions between human NK cells and macrophages in response to Salmonella infection. J. Immunol. 2009; 182(7): 4339–48.
  42. Bueno S.M., González P.A., Schwebach J.R., Kalergis A.M. T-cell immunity evasion by virulent Salmonella enterica. Immunol. Lett. 2007; 111(1): 14–20.
  43. Kotsar E.V., Krivulya A.D., Golubka O.V. [Current efficacy of antibiotic therapy for Salmonella bacteriocarrier]. Arkhivarius 2016; (11): 22–4. (In Russ.).
  44. Chainikova I.N. [Informative immunological parameters and biological properties of Salmonella in predicting the outcome salmonellosis infection]. Vestnik Orenburgskogo gosudarstvennogo universiteta 2005; (12): 58–62. (In Russ.).
  45. Timchenko V.N., ed. [Infectious diseases in children]. Saint-Petersburg: SpetsLit 2008; 576. (In Russ.).
  46. Akimkin V.G., Darbeyeva O.S., Kolkov V.F. [Bacteriophages: historical and modern aspects of their application: experience and prospects]. Klinicheskaya praktika 2010; (4): 48–54. (In Russ.).
  47. Ulukhanova L.U., Magomedov A.M. [The clinical efficacy of the immunomodulator «Kipferon» in the complex treatment of salmonellosis Typhimurium in children. Collection of scientific papers «Dagestan Medical Academy 75 years»]. Makhachkala: Izdatelstvo Dagestanskoy gosudarstvennoy meditsinskoy akademi, 2007; 61–3. (In Russ.).
  48. Chaynikova I.N., Smolyagin A.I., Ivanova A.S., Kalinina T.N., Skachkov M.V., Valyshev A.V., Bukharin O.V. [The effectiveness of the use of polyoxidonium for the rehabilitation of salmonella bacteria carriers]. Immunologiya 2004; 26(6): 339–43. (In Russ.).
  49. Bukharin O.V., Kirillov D.A., Sheyenkov N.V., Kirillov V.A. [Effect of cycloferon on the biological properties of bacterial intracellular pathogens]. Zhurnal mikrobiologii. epidemiologii i immunobiologii 2005; (3): 8–10. (In Russ.).
  50. Romantsov M.G. [Experience of using cycloferon in the treatment of intestinal infections in children]. Saint-Petersburg: Polysan , 2010; 15. (In Russ.).
  51. Starikova I.A. [The effectiveness of cycloferon in acute intestinal infections in children]. Vrach 2004; (7): 54–5. (In Russ.).
  52. Kozlov I.G., Аndronova T.M. [Medicinal effects through receptors of innate immunity. Collected articles «Modern ideas about the molecular mechanism of action glyukozaminilmuramildipeptida (GMDP)». Moscow, 2006; 27–37. (In Russ.).
  53. Kiryuhin A.V., Parfenov N.A., Maksimova Т.А., Lvov A.V., Parfenova N.A., Shenogina N.A., Chumakova M.M. [Optimization of treatment and often chronically ill children: licopid immunotherapy]. Rossiyskoy pediatricheskiy zhurnal 2001; (5): 27–9. (In Russ.).
  54. Ivanovа V.V., Ivanovа M.V., Levinа A.S., Zakina A.A., Tikhomirova O.V.. Zheleznikova G.F.. Aksenov O.A.. Komeleva E.V. [Modern principles of diagnosis and treatment of perinatal herpesvirus infections]. Rossiyskiy vestnik perinatologii i pediatrii 2008; (1): 10–8. (In Russ.).
  55. Svistunova A.S., Arshinova S.S., Klimova S.V. и др. [Clinical and immunological efficacy of the Likopid immunomodulator in pulmonary tuberculosis]. Immunologiya 2000; (5): 59–62. (In Russ.).
  56. Konorev M.R. [The effect of Licopid on the persistence of Helicobacter pylori in the gastric mucosa of patients with chronic gastritis]. Immunologiya. allergologiya. Infektologiya 2004; (2): 59–62. (In Russ.).
  57. Korovina N.A., Zakharova I.S., Kalinina M.V., Berezhnaya I.V. [Study of the effectiveness of Licopid for the correction of intestinal microbiocenosis disorders in children aged 1–7 years. Collection of scientific articles «Licopid in pediatric practice»]. Мoscow, 2006; 82–6. (In Russ.).
  58. Milutina L.N., Golubev A.O. [Experience with Likopid for sanitation of postinfectious Salmonella carriage in children]. Rossiyskiy vestnik perinatologii i pediatrii 2015; 6(4): 100–7. (In Russ.).


About the Autors

Lyudmila N. Milutina, MD, Leading Researcher, Clinical Department of Infectious Diseases, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Moscow, Russia; e-mail: milutina.ln@yandex.ru
Andrey O. Golubev, Cand. Med. Sci., Pediatrician, Z.A. Bashlyaeva City Children’s Clinical Hospital, Moscow Healthcare Department, Moscow, Russia; е-mail: ronin10000@mail.ru
Tatiana M. Andronova, PhD in Chemistry, Scientific Advisor, JSC Peptek, Moscow, Russia; е-mail: peptek@peptek.ru


Similar Articles

Back to Content

Бионика Медиа